2001
DOI: 10.1016/s0169-328x(01)00286-8
|View full text |Cite
|
Sign up to set email alerts
|

The neuroprotective actions of FK506 binding protein ligands: neuronal survival is triggered by de novo RNA synthesis, but is independent of inhibition of JNK and calcineurin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
34
0
5

Year Published

2002
2002
2013
2013

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 53 publications
(41 citation statements)
references
References 74 publications
2
34
0
5
Order By: Relevance
“…On the other hand, no significant increase of phosphorylated C-JUN protein was observed between 1 and 48 h after ischemia treatment in the CsA administration group, suggesting that calcineurin, a dephosphorylated oxidase, is involved in the expression of phosphorylation of C-JUN protein. Consistent with these results, it has been reported that JNK is activated by calcineurin (33) and that CsA inhibits signal transduction by JNK and p38 (34). In addition, when calcineurin activity was measured with time after cerebral ischemia in the CA1 area of the hippocampus, it increased 3-fold in the early phase after cerebral ischemia (after 1 h), compared to the level before ischemia, and continued to increase (up to 6-fold) for 24 h, following a transient decrease after 6 h, whereas it was repressed through all stages in the CsA administration group (35).…”
Section: +supporting
confidence: 87%
“…On the other hand, no significant increase of phosphorylated C-JUN protein was observed between 1 and 48 h after ischemia treatment in the CsA administration group, suggesting that calcineurin, a dephosphorylated oxidase, is involved in the expression of phosphorylation of C-JUN protein. Consistent with these results, it has been reported that JNK is activated by calcineurin (33) and that CsA inhibits signal transduction by JNK and p38 (34). In addition, when calcineurin activity was measured with time after cerebral ischemia in the CA1 area of the hippocampus, it increased 3-fold in the early phase after cerebral ischemia (after 1 h), compared to the level before ischemia, and continued to increase (up to 6-fold) for 24 h, following a transient decrease after 6 h, whereas it was repressed through all stages in the CsA administration group (35).…”
Section: +supporting
confidence: 87%
“…26,38 On the basis of our results, PI3K signaling is unlikely to mediate the effects of FKBP39 overexpression on Foxo localization, although it remains possible that FKBP39 may affect Akt independently of PI3K. Therefore, JNK signaling is a promising candidate for mediating at least some of the effects of FKBP39 overexpression, 24 especially considering the strong effect of FKBP39 overexpression on kinases downstream of Ras that are closely related to JNK family kinases. This issue clearly warrants future studies.…”
Section: Discussionmentioning
confidence: 80%
“…Nevertheless, current clinically available immunophilin ligands, including FK506 and cyclosporine A, are immunosuppressive, which limits their chronic use. However, neither calcineurin inhibition nor binding to FKBP-12 were found to be necessary for the neurotrophic effects of immunophilin ligands (Steiner et al, 1997;Costantini et al, 2001;Guo et al, 2001;Klettner et al, 2001;Zhang et al, 2001a;Tanaka et al, 2002b). This fact, together with the neuroprotective effects of immunophilin ligands in models of neurodegenerative disorders (reviewed by Pong and Zaleska, 2003), has led to the design of small ligands that bind to immunophilins, but are not immunosuppressive since they do not interact with calcineurin (e.g.…”
Section: Immunophilin Ligandsmentioning
confidence: 99%